Metraipolis › archive › dc_6dc6fd8952d2
Therapeutic Drug Monitoring in Special Circumstances in Inflammatory Bowel Disease — Europe PMC PMID:41302991
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41302991
- DOI
- 10.3390/jcm14227956
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T16:57:59.223Z
- SHA-256 of the archived text
2c6d5d9100f6a7720c9388630ec7cbeeb991f8fb9aafe3ffd27ee181e712942b- Stable URL of this page
https://metraipolis.com/documento/dc_6dc6fd8952d2
How to cite
Therapeutic Drug Monitoring in Special Circumstances in Inflammatory Bowel Disease — Europe PMC PMID:41302991 — Europe PMC (en), https://europepmc.org/article/MED/41302991 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6dc6fd8952d2 (Metraipolis archive dc_6dc6fd8952d2, sha256 2c6d5d9100f6a7720c9388630ec7cbeeb991f8fb9aafe3ffd27ee181e712942b)
BibTeX
@misc{dc6dc6fd8952d2,
title = {Therapeutic Drug Monitoring in Special Circumstances in Inflammatory Bowel Disease — Europe PMC PMID:41302991},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41302991},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6dc6fd8952d2; sha256 2c6d5d9100f6a7720c9388630ec7cbeeb991f8fb9aafe3ffd27ee181e712942b},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41302991. Agents can read the archived copy with the MCP tool read_document.